Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Semaglutide GLP-1s multifaceted mechanism of action helps reduce caloric intake by lowering hunger and increasing feelings of fullness
Side effect comparison: tirzepatide versus retatrutide Understanding the side effect differences helps you prepare for what the transition may bring
Specifications+ Storage and Handling+ Store refrigerated at 2 to 8C, away from light
Tracking numbers are available after 3 days of processing
tirzepatide is a dual agonist (GIP/GLP-1) Peak weight loss : Retatrutide showed 28.7% at 68 weeks (Phase 3 TRIUMPH-4) and 24.2% at 48 weeks (Phase 2) vs tirzepatide 20.9% (Phase 3) Liver fat : Retatrutide's glucagon agonism provides pronounced hepatic fat reduction (up to 82%) Regulatory status : Tirzepatide is FDA-approved
